| Entry |
|
|---|
| Name |
Nimustine hydrochloride (JAN);
Nidran (TN) |
|---|
| Formula |
C9H13ClN6O2. HCl
|
|---|
| Exact mass |
308.0555
|
|---|
| Mol weight |
309.15
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Therapeutic category: | 4219 |
| Product (DG00679): | D01059<JP> |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Target |
DNA |
|---|
| Interaction |
|
|---|
| Structure map |
| map07040 | Antineoplastics - alkylating agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AD Nitrosoureas
L01AD06 Nimustine
D01059 Nimustine hydrochloride (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
421 Alkylating agents
4219 Others
D01059 Nimustine hydrochloride (JAN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01724 Nitrosourea
DG00679 Nimustine
D01059 Nimustine hydrochloride
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01724 Nitrosourea
DG00679 Nimustine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C8y C 19.8800 -19.6000
2 N5x N 19.8800 -18.2000
3 C8y C 21.0700 -17.5000
4 C8y C 22.2600 -18.2000
5 C8x C 22.2600 -19.6000
6 N5x N 21.0700 -20.3000
7 C1a C 18.6200 -20.3000
8 N1a N 21.0700 -16.1000
9 C1b C 23.5200 -17.5000
10 N1b N 24.7100 -18.2000
11 C5a C 25.9000 -17.5000
12 O5a O 25.9000 -16.1000
13 N1c N 27.1600 -18.2000
14 C1b C 28.3500 -17.5000
15 C1b C 29.5400 -18.2000
16 X Cl 30.7300 -17.5700
17 N2b N 27.1600 -19.6000
18 O3a O 25.9000 -20.3000
19 X Cl 33.8100 -17.6400
BOND 18
1 2 3 1
2 9 10 1
3 3 4 2
4 10 11 1
5 4 5 1
6 11 12 2
7 5 6 2
8 11 13 1
9 6 1 1
10 13 14 1
11 14 15 1
12 1 7 1
13 15 16 1
14 13 17 1
15 3 8 1
16 1 2 2
17 4 9 1
18 17 18 2
|
|---|
